NTRA | NateraNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$388.63
+$9.71 (+2.56%)

Natera (NTRA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits above the 50 and the 200; on the 4-hour it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $388.63 vs 50 $379.21 / 200 $267.62
Projection
No cross projected
Test
No active test
Last cross
Golden cross 4 Jun 2026 ยท projected 6 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
above both $414.30 vs 50 $260.46 / 200 $144.29
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 8 Jul 2024 ยท projected 22 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $388.63 vs 50 $404.74 / 200 $326.87
Projection
No cross projected
Test
No active test
Last cross
Golden cross 15 Jun 2026 ยท projected 27 bars out

Cross history

30
crosses on record since 2017
16 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
15 Jun 2026Golden4-hour27 bars outNot tested
4 Jun 2026Golden flatdaily6 bars out1 bar cross test
21 May 2026Death flatdaily5 bars out4 bar cross test
2 Mar 2026Death4-hour30 bars outNot tested
29 Sep 2025Golden moderatedaily28 bars out3 bar cross test

About NTRA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$531M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.